PriceTargets.com logo

Carl Zeiss Meditec - AFX Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: €0.00
  • Forecasted Upside: -100.00%
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
€42.84 As of 12/3/2025 01:00 AM ET
▼ -0.1 (-0.23%)

This chart shows the closing price for AFX by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Carl Zeiss Meditec Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for AFX and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for AFX

Analyst Price Target is €0.00
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for Carl Zeiss Meditec in the last 3 months. The average price target is €0.00, with a high forecast of €0.00 and a low forecast of €10,000,000.00. The average price target represents a -100.00% upside from the last price of €42.84.

This chart shows the closing price for AFX for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is N/A

The current consensus among 0 contributing investment analysts is to n/a stock in Carl Zeiss Meditec. This N/A consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
6/12/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
9/10/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
12/9/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/9/2025
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
6/7/2025
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
9/5/2025
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
11/4/2025
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
12/4/2025

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
3/31/2023Deutsche Bank AktiengesellschaftSet Target€175.00
3/22/2023Deutsche Bank AktiengesellschaftSet Target€175.00
3/22/2023Hauck Aufhäuser Investment BankingSet Target€195.00
3/22/2023UBS GroupSet Target€162.00
3/9/2023UBS GroupSet Target€162.00
2/24/2023Deutsche Bank AktiengesellschaftSet Target€175.00
2/13/2023Berenberg BankSet Target€138.00
2/13/2023Deutsche Bank AktiengesellschaftSet Target€167.00
2/10/2023UBS GroupSet Target€156.00
2/6/2023Berenberg BankSet Target€138.00
2/6/2023Hauck Aufhäuser Investment BankingSet Target€195.00
1/25/2023Deutsche Bank AktiengesellschaftSet Target€167.00
1/25/2023UBS GroupSet Target€156.00
12/15/2022UBS GroupSet Target€156.00
12/12/2022Deutsche Bank AktiengesellschaftSet Target€167.00
12/12/2022Hauck Aufhäuser Investment BankingSet Target€195.00
12/9/2022UBS GroupSet Target€154.00
11/28/2022UBS GroupSet Target€154.00
10/31/2022Deutsche Bank AktiengesellschaftSet Target€167.00
10/5/2022Berenberg BankSet Target€135.00
9/22/2022Berenberg BankSet Target€135.00
9/13/2022Berenberg BankSet Target€135.00
9/13/2022Hauck Aufhäuser Investment BankingSet Target€195.00
8/8/2022Deutsche Bank AktiengesellschaftSet Target€156.00
8/8/2022Hauck Aufhäuser Investment BankingSet Target€195.00
8/5/2022UBS GroupSet Target€170.00
7/20/2022Deutsche Bank AktiengesellschaftSet Target€156.00
7/14/2022Hauck Aufhäuser Investment BankingSet Target€195.00
6/27/2022Deutsche Bank AktiengesellschaftSet Target€156.00
5/16/2022UBS GroupSet Target€170.00
5/16/2022Deutsche Bank AktiengesellschaftSet Target€210.00
4/21/2022Hauck and AufhaeuserSet Target€215.00
4/19/2022Deutsche Bank AktiengesellschaftSet Target€210.00
3/16/2022UBS GroupSet Target€170.00
2/14/2022HSBCSet Target€146.00
2/14/2022Deutsche Bank AktiengesellschaftSet Target€210.00
2/14/2022Hauck and AufhaeuserSet Target€215.00
1/25/2022Hauck and AufhaeuserSet Target€215.00
12/13/2021Deutsche Bank AktiengesellschaftSet Target€210.00
12/10/2021Berenberg BankSet Target€180.00
12/10/2021Kepler Capital MarketsSet Target€180.00
11/1/2021Deutsche Bank AktiengesellschaftSet Target€210.00
8/11/2021Nord/LBSet Target€192.00
7/20/2021Hauck and AufhaeuserSet Target€215.00
7/20/2021Berenberg BankSet Target€180.00
7/9/2021Hauck and AufhaeuserSet Target€180.00
6/21/2021Deutsche Bank AktiengesellschaftSet TargetBuy€170.00
5/26/2021Nord/LBSet TargetBuy€172.00
5/26/2021Berenberg BankSet TargetNeutral€149.00
5/17/2021DZ BankReiterated RatingNeutral
5/11/2021Deutsche Bank AktiengesellschaftSet TargetBuy€170.00
4/20/2021Kepler Capital MarketsSet TargetNeutral€145.00
4/20/2021Independent ResearchSet TargetSell€97.00
4/20/2021Deutsche Bank AktiengesellschaftSet TargetBuy€170.00
4/19/2021Berenberg BankSet TargetNeutral€127.00
3/3/2021Nord/LBSet TargetBuy€143.00
2/11/2021Independent ResearchSet TargetSell€86.00
2/9/2021Deutsche Bank AktiengesellschaftSet TargetBuy€150.00
2/8/2021UBS GroupSet TargetNeutral€126.00
1/21/2021DZ BankReiterated RatingNeutral
1/20/2021Berenberg BankSet TargetNeutral€127.00
1/20/2021Deutsche Bank AktiengesellschaftSet TargetBuy€140.00
12/16/2020Nord/LBSet TargetNeutral€110.00
12/14/2020UBS GroupSet TargetNeutral€126.00
(Data available from 12/4/2020 forward)

News Sentiment Rating

0.00 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 1 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
5/8/2025
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
6/7/2025
  • 2 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
7/7/2025
  • 1 very positive mentions
  • 1 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
8/6/2025
  • 0 very positive mentions
  • 0 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
9/5/2025
  • 0 very positive mentions
  • 2 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
10/5/2025
  • 0 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
11/4/2025
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/4/2025

Current Sentiment

  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

Very Positive

  • No very positive mentions tracked during this time.
Carl Zeiss Meditec logo
Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, such as ametropia (refraction), cataracts, glaucoma, and renital disorders. This segment also provides devices for general ophthalmological examination and care, including slit lamps, refractometers, tonometers, optical coherence tomography devices, and fundus cameras; and devices for functional diagnostics (perimeters), as well as digital products for storage, evaluation, and sharing of clinical data. In addition, this segment offers surgical ophthalmology products comprising surgical microscopes, biometers, phacoemulsification, and vitrectomy devices; intraocular lenses for cataract patients; and systems and consumables for laser eye surgery. The Microsurgery segment provides products and solutions for invasive surgical treatments; and solutions in the area of ear, nose and throat, plastic and reconstructive, neuro, dental, and spinal surgeries. It serves physicians in various fields and hospitals. The company was founded in 1846 and is headquartered in Jena, Germany. Carl Zeiss Meditec AG is a subsidiary of Carl Zeiss AG.
Read More

Today's Range

Now: €42.84
Low: €42.74
High: €44.02

50 Day Range

MA: €44.10
Low: €41.40
High: €47.72

52 Week Range

Now: €42.84
Low: €54.60
High: €123.75

Volume

89,554 shs

Average Volume

94,405 shs

Market Capitalization

€3.99 billion

P/E Ratio

22.89

Dividend Yield

2.02%

Beta

0.98

Frequently Asked Questions

What sell-side analysts currently cover shares of Carl Zeiss Meditec?

The following equities research analysts have issued reports on Carl Zeiss Meditec in the last twelve months:
View the latest analyst ratings for AFX.

What is the current price target for Carl Zeiss Meditec?

0 Wall Street analysts have set twelve-month price targets for Carl Zeiss Meditec in the last year. has the lowest price target set, forecasting a price of €10,000,000.00 for Carl Zeiss Meditec in the next year.
View the latest price targets for AFX.

What is the current consensus analyst rating for Carl Zeiss Meditec?

Carl Zeiss Meditec currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for AFX.

What other companies compete with Carl Zeiss Meditec?

Other companies that are similar to Carl Zeiss Meditec include Sartorius Aktiengesellschaft, Gerresheimer, Essilor International Société Anonyme, Fielmann Group and Sartorius Aktiengesellschaft. Learn More about companies similar to Carl Zeiss Meditec.

How do I contact Carl Zeiss Meditec's investor relations team?

Carl Zeiss Meditec's physical mailing address is Goeschwitzer Strasse 51-52, JENA, 07745, Germany. The company's listed phone number is +49-3641-2200. The official website for Carl Zeiss Meditec is www.zeiss.com. Learn More about contacing Carl Zeiss Meditec investor relations.